Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCDC125 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | WTIP | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | IQCD | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | ERC2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | NMU | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | FAM86C1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | MMP16 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | DYNLL1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | SCAF1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | FABP2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |